Overview

Comparison of Liraglutide and Glimepiride on Blood Sugar Control in Subjects With Type 2 Diabetes

Status:
Completed
Trial end date:
2001-10-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this trial is to establish the dose response relationship on glycaemic control of five dose levels of NNC90-1170.
Phase:
Phase 2
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Glimepiride
Liraglutide